Skip to main content
. 2017 Aug 24;8(43):74791–74805. doi: 10.18632/oncotarget.20422

Figure 1. A schematic illustration of in vivo and in vitro experimental design.

Figure 1

(A). in vivo experimental design; (B). in vitro experimental design. T1D, type 1 diabetes; MI/R, myocardial ischemia-reperfusion; DATS, diallyl trisulfide; Com.C, Compound C; LY, LY294002; HG, high glucose; SIR, simulated ischemia-reperfusion; 2ME, 2-methoxyestradiol.